I maintain a hold rating for National Vision Holdings due to uncertainty about whether strategic initiatives will improve fundamentals. EYE's 4Q24 earnings showed 3.9% y/y growth, but profitability remains an issue, with a net loss of $29.4 million. Positive signs include a shift toward managed care customers and store optimizations, but CSSG and profitability need to improve.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Continued strength in Managed Care aids National Vision's fourth-quarter 2024 performance.
National Vision Holdings Inc (NASDAQ:EYE ) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Tamara Gonzalez - VP of Investor Relations Reade Fahs - CEO Alex Wilkes - President Melissa Rasmussen - CFO Conference Call Participants Michael Lasser - UBS Anthony Chukumba - Loop Capital Markets Taylor Brimberg - Wells Fargo Simeon Gutman - Morgan Stanley Meghan Holtz - Jefferies Adrienne Yih - Barclays Molly Baum - Bank of America Operator Good day, and thank you for standing by. Welcome to the Fourth Quarter 2024 National Vision Holdings Earnings Conference Call.
National Vision (EYE) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.02 per share a year ago.
National Vision continues to draw investors' attention with its strategic transformation efforts, while positive industry trends should favor its growth.
National Vision (EYE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
National Vision (EYE) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of National Vision (EYE) and Clorox (CLX). But which of these two stocks is more attractive to value investors?
Investors are optimistic about EYE stock, courtesy of its share gain in the Owned and Host segments.
The strong execution of strategic initiatives and robust market expansion of the Owned and Host segment bode well for National Vision.